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Background: Sodalis glossinidius, a vertically transmitted microbial symbiont of the tsetse fly, is currently considered
as a potential delivery system for anti-trypanosomal components that reduce or eliminate the capability of the
tsetse fly host to transmit parasitic trypanosomes, an approach also known as paratransgenesis. An essential step in
developing paratransgenic tsetse is the stable colonization of adult flies and their progeny with recombinant Sodalis
bacteria, expressing trypanocidal effector molecules in tissues where the parasite resides.
Results: In this study, Sodalis was tested for its ability to deliver functional anti-trypanosome nanobodies (Nbs) in
Glossina morsitans morsitans. We characterized the in vitro and in vivo stability of recombinant Sodalis (recSodalis)
expressing a potent trypanolytic nanobody, i.e. Nb_An46. We show that recSodalis is competitive with WT Sodalis in
in vivo conditions and that tsetse flies transiently cleared of their endogenous WT Sodalis population can be successfully
repopulated with recSodalis at high densities. In addition, vertical transmission to the offspring was observed. Finally,
we demonstrated that recSodalis expressed significant levels (ng range) of functional Nb_An46 in different tsetse fly
tissues, including the midgut where an important developmental stage of the trypanosome parasite occurs.
Conclusions: We demonstrated the proof-of-concept that the Sodalis symbiont can be genetically engineered to
express and release significant amounts of functional anti-trypanosome Nbs in different tissues of the tsetse fly.
The application of this innovative concept of using pathogen-targeting nanobodies delivered by insect symbiotic
bacteria could be extended to other vector-pathogen systems.
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The contemporary response to vector-borne infectious
diseases still mainly relies on low-technology interven-
tions, with a major emphasis on vector control through
the use of insecticides. As vector-borne diseases con-
tinue to present significant threats to human, animal
and plant health, there is an urgent need to develop
control efforts that remain effective over time. Genetic-
ally modified disease vectors that are rendered resistant
(refractory) to pathogen transmission can provide unique
tools for developing new or complementing existing con-
trol strategies (reviewed by [1]). Paratransgenesis is one* Correspondence: ldevooght@itg.be; jvdabbeele@itg.be
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article, unless otherwise stated.such approach that aims to reduce vector competence by
genetically modifying symbionts of disease vectors and has
been demonstrated for Rhodnius prolixus, the triatomine
vector of Chagas disease [2] and Anopheles gambiae [3,4],
the principal malaria vector in Africa.
A paratransgenic approach in tsetse flies, the sole
vector of major African trypanosome parasites (T. brucei
sp. and T. congolense), is of high interest since tsetse flies
are not amenable to germ-line transformation due to their
viviparous reproductive biology (intrauterine development
and parturition of live offspring [5]). The tsetse fly harbors
a natural commensal bacterium i.e. Sodalis glossinidius,
which is ideally suited as a paratransgenic platform organ-
ism since it i) resides in different tsetse tissues that are in
close proximity to pathogenic trypanosomes (e.g. midgut)
[6]; ii) can be cultured and genetically modified in vitrotral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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iv) is restricted to the tsetse host niche ensuring that this
symbiont is a safe candidate for use in the paratransgenic
strategy [10].
The characteristics of the selected effector molecule
will largely determine the efficacy and specificity of this
paratransgenesis approach. Low specificity will generally
result in bystander effects that could have a direct or
indirect fitness cost for the arthropod. The use of highly
specific compounds from the adaptive immune system
of vertebrates such as antibody derived fragments is
likely to enable highly specific effects without conferring
a selective disadvantage to the (para)transgenic arthro-
pods [11]. Nanobodies® (Nbs), representing the smallest
known intact antigen-binding fragments derived from
camelid heavy-chain only antibodies (HCAbs) [12], are
therefore considered as excellent candidates to increase
the immune competence of tsetse. Nanobodies targeting
distinct epitopes of the variant-specific surface glycopro-
tein (VSG), abundantly present on the surface of blood-
stream trypanosomes have already been identified, some
of which were shown to exert direct in vitro and in vivo
trypanolytic activity by interfering with the complex
endocytotic machinery that is organized in the flagellar
pocket of this parasite [13]. Recently, we developed re-
combinant Sodalis (recSodalis) strains expressing func-
tional anti-trypanosome nanobodies. These strains were
shown to release considerable amounts of functional
anti-trypanosome Nbs to the extracellular culture envir-
onment and to have no negative effects on the bacter-
ium in an in vitro context [14].
Another prerequisite in developing paratransgenic tse-
tse flies is the development of a methodology that allows
the stable repopulation of tsetse flies with recSodalis
strains expressing trypanosome-interfering proteins in
insect tissues where trypanosome parasites reside. Previ-
ously, recSodalis expressing green fluorescent protein
(GFP) has been successfully introduced into tsetse through
thoracic microinjection [6]. Here, GFP-expressing Sodalis
was found to be present in the haemolymph and gut
tissues of injected females and their progeny. However, to
date no studies have focused on the densities whereby
genetically modified Sodalis, expressing heterologous
genes, are maintained within the fly and the efficiency
of their transmission to the offspring.
In this study, a recSodalis strain was tested for its ability
to deliver functional anti-trypanosome Nbs in the tsetse
fly Glossina morsitans morsitans. The in vivo long-term
stability of the recombinant strain and transmission to the
progeny was measured using a quantitative PCR (qPCR)
analysis. We show that recSodalis expressing a potent try-
panolytic nanobody, i.e. Nb_An46, was stably maintained
in vivo only when the WT Sodalis population was signifi-
cantly reduced (>95% of the normal population) prior torecSodalis introduction. Furthermore, we demonstrated
that significant levels of functional Nb_An46 accumulated
in different fly tissues, including the midgut where
an important developmental stage of the trypanosome
parasite occurs.
Results
In vitro culture characteristics of recombinant Sodalis
expressing Nb_An46
Prior to the introduction of recSodalis into experimental
flies, the Nb expression profile, in vitro growth rate and
plasmid stability of recSodalis expressing a FliCpelBN-
b_An46 fusion protein (Sod:FliCpelBNb46fliC) was estab-
lished. Extracellular Nb_An46 expression was confirmed
by Western blot analysis of supernatant from cultures
grown to the beginning of stationary phase (OD600 0.5-
0.6) (Figure 1). Nb_An46 expression and release was
quantified at different time points during bacterial
growth over a 10-day period by measuring the concen-
tration of active Nb in the whole cell lysate and culture
medium using a VSG-binding ELISA assay. Functional
Nb_An46 was expressed from day 2 onwards and accu-
mulated in the culture medium to a concentration of
88 ng/ml by day 10 (Figure 2B). RecSodalis showed
normal growth kinetics (Figure 2A) with cell popula-
tion doubling times comparable to a WT Sodalis strain
i.e., 15.0 hrs and 14.8 hrs respectively. The number of
plasmid copies per cell was estimated to be approxi-
mately 20 during the lag and exponential phases of Sod:
FliCpelBNb46fliC grown in the presence of antibiotic
selection. The stability of the FliCpelBNb46fliC plasmid
in recSodalis was measured by maintaining the recom-
binant bacteria in log phase growth for 27 generations
in liquid MM medium in the absence of antibiotic
selection. Colony counts on antibiotic-selective plates
showed that 94% of the Sodalis population remained
antibiotic resistant after 27 generations (corresponding
to a 2-month test period) (Table 1).
Prior reduction of WT Sodalis is a prerequisite for an
efficient host colonization with recSodalis
We explored the capability of recSodalis to colonize
the tsetse fly after introduction through intrathoracic
injection. We first evaluated the necessity of the prior
reduction of the WT Sodalis population in tsetse for
recSodalis to establish and colonize its host. In female
flies that received 3 streptozotocin supplemented blood
meals, the WT Sodalis population was reduced by 95%
and 88% in abdomen and thorax tissues respectively,
compared to flies fed on normal blood. This treatment
did not affect the obligatory Wigglesworthia symbiont
population that mainly resides in the tsetse fly abdomen
(Additional file 1: Figure S1). Next, the in vivo persistence











Figure 1 Qualitative analysis of extracellular Nb_An46
expressed by Sod_pFliCpelBNb46fliC in vitro. The extracellular
expression of Nb_An46 was analyzed by immunoblotting of the
medium supernatant using an anti-His antibody (1:1000 Serotec) for
detection. Presented data are representative for at least three
independent experiments. The PageRuler 10–170 kDa prestained
protein ladder (Fermentas) was used as a molecular size marker (MM).
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5×104 CFU Sod_FliCpelBNb46fliC was evaluated using
qPCR (Figure 3). In streptozotocin-treated flies, recSodalis
was able to proliferate inside its host, reaching densities
of 10- and 20-fold the initial injected dose in respect-
ively abdomen and thorax, whereas in non-treated flies
the injected recSodalis population was not able to
expand and remained present at its initial density.
The effect of differential doses of recSodalis inoculum on
tsetse fly colonization and viability
We determined the optimal dose for recSodalis injection
in terms of host colonization and its viability. For this,
streptozotocin-treated male flies were microinjected witheither 5 × 104, 5 × 105, 107 and 5 × 107 CFU Sod_FliC-
pelBNb46fliC and recSodalis densities in abdomen and
thorax tissues were determined 7 and 14 days post-
injection (dpi) using qPCR (Figure 4). Injection of 5 ×
107 CFU resulted in an increased fly mortality (up to
59% mortality 14 dpi), whereas limited mortality (≤25%
14 dpi) was observed within the other injection groups.
In these groups, recSodalis was able to repopulate the
abdomen and thorax to densities comparable to natural
Sodalis levels present in WT flies (on average respect-
ively 2.5 × 106 and 1.5 × 106 CFU), demonstrating that a
wide range of recSodalis doses (i.e. 5 × 104 to 1 × 107)
are suitable to initiate colonization without affecting fly
viability.
recSodalis persists in the tsetse fly and is vertical
transmitted to the offspring but at a low extent
The in vivo persistence of Sod_FliCpelBNb46fliC was
evaluated by qPCR based estimation of the amount of
recSodalis CFU in abdomen and thorax tissues of
streptozotocin-treated male flies injected with 1 × 107
recombinant CFU over a 28 day period (Figure 5A).
Sod_FliCpelBNb46fliC was able to remain present at
high densities in abdomen and thorax tissues of experi-
mental flies throughout the course of the 28-day observa-
tion period. In flies injected with Sod_FliCpelBNb46fliC,
the entire Sodalis population in abdomen and thorax
remained recombinant. Next, we evaluated recSodalis
densities in the haemolymph and midgut tissues of flies
injected with 1 × 107 recombinant CFU (Figure 5B).
Sod_FliCpelBNb46fliC was able to reach the fly midgut
where it persisted at densities between 5 × 104 and
1 × 105 CFU (DNA equivalent) throughout the 21-day
observation period. In these flies the obligatory Wig-
glesworthia symbiont population was not affected by the
presence of Sod_FliCpelBNb46fliC (Additional file 1:
Figure S2) nor did we observe any effect upon the
fecundity of female recSodalis colonized flies. Trans-
mission dynamics of the recombinant bacteria to the F1
progeny was evaluated by qPCR. Sod_FliCpelBNb46fliC
was transmitted to the F1 generation, although non-
plasmid containing Sodalis were dominant in these flies.
Indeed, Sod_FliCpelBNb46fliC constituted only 7 and
5% of the entire Sodalis population in respectively abdo-
men and thorax (Figure 6).
Functional Nb_An46 is expressed in different tsetse fly
tissues
Nb_An46 expression in flies injected with 1 × 107 Sod_FliC-
pelBNb46fliC CFU was quantified using a VSG-binding
ELISA. Nanobody concentrations were determined at
different time points post-injection in whole abdomen
and thorax extracts, haemolymph and midgut (Figure 7).
Functional Nb_An46 accumulated in haemolymph and
Sod_FliCpelBNb46fliC















































Figure 2 In vitro characteristics of recSodalis expressing Nb_An46. A) Growth curve analysis of WT Sodalis and Sod_pFliCpelBNb46fliC. The
error bars show the ± SD of two biological replicates. Samples were taken every 24 h. B) ELISA-based Nb_An46 quantitation (bar-chart) of the
intra- and extracellular nanobody concentration produced by Sod_pFliCpelBNb46fliC at selected time points in relation to bacterial cell density
(OD600nm, solid line) using a 6 × His tag specific detection antibody. Values are presented as ng recombinant protein per ml culture medium.
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continuous transgene expression by recSodalis in these
tissues. In the thorax the Nb_An46 concentration in-
creased from 22 ng on day 14 post-injection to 35 ng on
day 21. Although significant quantities of active Nb_An46
were detected in abdomen and midgut using a VSG-
binding ELISA, the accuracy of this quantitation could
have been hampered by the abundant presence of pro-
teolytic enzymes in the tsetse fly gut, probably resulting in
fast degradation of the nanobodies in the tissue homoge-
nates and possibly resulting in the underestimation of
the active Nb content of the non-digestive part of the
tsetse fly gut.
Discussion
The aim of this study was to develop a functional Sodalis-
based shuttle system that is able to deliver and express
anti-trypanosome nanobodies within the tsetse fly. In this
study a recombinant Sodalis strain was used expressing
a potent trypanolytic nanobody Nb_An46 through a
plasmid-based expression system. The functionality of
the system was assessed by monitoring if recSodalis
bacteria can (1) establish a stable population in the tsetse
fly over time, (2) express significant levels of activeTable 1 Stability of pFliCpelBNb46FliC in Sodalis under
nonselective growth conditions





Plasmid stability was expressed as the ratio between the number of colonies
formed on MM blood agar plates with (50 μg/ml) and without kanamycin.anti-trypanosome nanobodies in the tsetse fly and (3)
be efficiently transferred to the offspring.
Although the growth characteristics of Nb-expressing
recSodalis were shown to be similar with those of the
WT Sodalis in in vitro culture conditions it is plausible
that in the tsetse fly in vivo environment the endogenous
WT bacteria could have a competitive advantage over
the introduced recombinant bacteria. Our results clearly
suggest that recSodalis is competitive with WT Sodalis
in in vivo conditions, however the maximal total Sodalis
density in the inner tsetse fly environment seems to be
limited to approximately 5×106 CFU. Indeed, only when
the existing WT Sodalis population is priorly reduced
(>95%) by a selective antibiotic treatment, the intro-
duced recSodalis population is able to maintain and pro-
liferate to comparable density levels observed for wildtype
Sodalis in normal tsetse flies. This recSodalis population is
then able to outgrow the WT population which remains
present at low density. In contrast, in non-treated flies
recSodalis is not able to displace the WT Sodalis popula-
tion but remains present at low density, confirming the
importance of creating a WT Sodalis deprived niche that
allows recSodalis to proliferate inside its host.
An important factor when using episomally located
plasmids in a paratransgenic system is the persistence of
these recombinant strains in the tsetse fly in the absence
of antibiotic selection as premature loss of expression
due to plasmid instability would not be desirable. There-
fore, we assessed the stability of the recombinant
strains during in vitro culture maintenance and after
re-introduction in the tsetse fly. Results from the bacter-
ial plate assay showed that in the absence of selection
pressure in the culture medium the FliCpelBNb46fliC
plasmid proved to be stably maintained with 94% of the
Abdomen




























































Figure 3 Number of recSodalis CFU (DNA equivalent) in abdomen and thorax of streptozotocin-treated and non-treated male flies
injected with 5x104 CFU of Sod_pFliCpelBNb46fliC. Prior to injection, treated flies were given three blood meals supplemented with 20 μg/ml
streptozotocin during the first week after emergence, while non-treated flies received normal blood meals. qPCR on the pFliCpelBNb46FliC plasmid
was used as a means to estimate the number of recSodalis. The bars represent the mean recSodalis CFU (DNA equivalent) ± SD present in abdomen
and thorax tissues of at least 5 individual flies from each treatment group at the time of sampling. The number of CFU (DNA equivalent) is represented
in log scale on the y-axis. P values were calculated using the Mann–Whitney U test (*p <0.05, **p <0.01).
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ations. This strong long-term plasmid retention in
recSodalis was not always observed as for another strain
(containing the FliCpelBNb33fliC plasmid) a complete
plasmid loss in the total Sodalis population after 20
generations in culture. We postulate that the strong per-



























Figure 4 Number of recSodalis CFU (DNA equivalent) present in abdo
5×104, 5×105, 1×107 and 5×107 CFU of Sod_pFliCpelBNb46fliC. qPCR
estimate the number of recSodalis. The bars represent the mean recSod
of at least 5 individual flies from each treatment group at the time of samp
on the y-axis. P values were calculated using the Kruskal–Wallis test followeculture in the absence of a selection pressure is related to
the high plasmid copy number that is observed in this
strain and which was 20 fold higher than in the unstable
Sod_FliCpelBNb33fliC strain.
Sod_FliCpelBNb46fliC remained present at high dens-
ities in the fly throughout the 28 day observation period.
Furthermore, recSodalis was able to disseminate into theA14 T14
injection
men (A) and thorax (T) tissues of flies injected with respectively
on the pFliCpelBNb46FliC plasmid was used as a means to
alis CFU (DNA equivalent) ± SD present in abdomen and thorax tissues
ling. The number of CFU (DNA equivalent) is represented in log scale
d by Dunn's test for multiple comparison (*p <0.05, **p <0.01).
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Figure 5 Evaluating the host colonization properties of recSodalis. A) Number of recSodalis CFU (DNA equivalent) present in abdomen
(solid red line) and thorax (solid black line) of Streptozotocin-treated flies injected with 1x107 CFU of Sod_pFliCpelBNb46fliC versus the total number
of Sodalis CFU DNA equivalent (WT + recombinant Sodalis) present in abdomen (dashed red line) and thorax tissues (dashed black line). B) The number
of recombinant and total Sodalis CFU (DNA equivalent) present in haemolymph (solid/dashed blue line) and midgut (solid/dashed grey line) were
estimated as described above. Data points represent the mean recSodalis and total Sodalis CFU (DNA equivalent) ± SD present in the respective
tissues of at least 5 individual flies at the time of sampling. The number of CFU (DNA equivalent) is represented in log scale on the y-axis.
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flies harboring WT symbionts. Furthermore, the majority
of the total Sodalis population remained recombinant for
the duration of the experiment indicating that the high
plasmid stability that was observed in the in vitro culture















Figure 6 Transmission of recSodalis to the F1 generation was
evaluated. Recombinant and total Sodalis numbers were estimated
as described above in abdomen and thorax of the F1 progeny (freshly
emerged) produced by streptozotocin-treated female flies injected
with 5 × 104 CFU of Sod_pFliCpelBNb46fliC. Data points represent the
mean recSodalis and total Sodalis CFU (DNA equivalent) ± SD present
in the respective tissues of at least 5 individual flies at the time of
sampling. The number of CFU (DNA equivalent) is represented in
log scale on the y-axis.Although transmission to the F1 generation was ob-
served, this seemed to be highly inefficient as only a
small percentage of the total Sodalis population was
found to be recombinant. This could be due to plasmid
loss by recSodalis during the 30-day pupal stage or the
inability of recSodalis to efficiently colonize the milk
glands upon injection in the adult female fly which is a
prerequisite for recSodalis transmission to the intra-
uterine larvae through the milk secretion. Indeed ana-
lysis of transcripts encoding Sodalis motility genes, fliC
and motA, and cell invasion genes, invA1 and invA2, are
up regulated in the larval and early pupal stages, and not
in adult tsetse flies [15]. These results indicate that the
Type-III secretion system and flagellum may be import-
ant for the transmission and establishment of symbiont
infections in the intra-uterine progeny. Our results
clearly indicate that for a successful use of Sodalis as
paratransgenic vehicle in the tsetse fly several method-
ologies should still be improved allowing i) the gener-
ation of more stable recSodalis i.e. through an efficient
methodology to insert exogenous DNA directly into the
bacterial genome and ii) a more efficient transfer of the
recSodalis to the next generations.
RecSodalis was found to continuously express func-
tional nanobody in the tsetse fly as indicated by the
Nb_An46 accumulation in the haemolymph over time.
Abdomen and midgut extracts from the majority of
insects that carried the recombinant nanobody-producing
bacteria were positive in the ELISA, indicating the pres-
ence of functional Nb in these tissues. However the abun-
























  7 dpi
14 dpi
21 dpi
Figure 7 ELISA based quantitation of the amount of Nb_An46
present in haemolymph, abdomen, thorax and midgut of
streptozotocin-treated flies injected with 1×107 CFU of
Sod_pFliCpelBNb46fliC at selected time points (○:7 dpi, ▽: 14
dpi, □: 7 dpi) using a 6 × His tag specific detection antibody.
Values are presented as ng nanobody per whole tissue extract or
1 μl haemolymph.
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accurate quantification of the Nb expression in this
tissue. These results suggest the benefit of lowering
the susceptibility of potential effector proteins to pro-
teolytic degradation especially when they have to be
functional in a digestive tissue such as the tsetse fly
midgut. Nbs have the advantage that they can be
mutagenized and selected for increased proteolytic
stability [16].
From our experimental data, the expected levels of
in vivo Nb expression are in the lower ng range. How-
ever, these levels of Nb expression should be sufficient
to interfere with trypanosome development given that
an infective blood meal of a tsetse fly in nature is esti-
mated to contain around 103 parasites as the average
parasitaemia in T. brucei infected cattle fluctuates from
1.5 × 105 parasites per ml during the acute phase of
infection to 5 × 104 parasites per ml during the chronic
phase [17] and in vitro studies have shown that nanomo-
lar concentrations of trypanolytic Nbs are sufficient to
saturate >95% of the surface VSG molecules and to pro-
voke efficient trypanosome lysis [13,18]. Indeed, since a
VSG:Nb molar ratio of 1:20 is sufficient to cause effi-
cient lysis, 5 ng of Nb_An46 should be adequate to effi-
ciently lyse 103 parasites.Conclusion
These data are the first to show the potential of Sodalis
as a delivery system for anti-trypanosome effector mole-
cules in tsetse fly tissues relevant for trypanosome develop-
ment. Given the ability of recombinant S. glossinidius to
efficiently establish in different tsetse fly tissues at high
densities and their capacity to release significant levels
of functional anti-trypanosome Nbs in tissues were
trypanosomes reside, the foundation has been laid for
further exploration of the inhibitory effect on trypano-
some development in the tsetse fly. Moreover, a para-
transgenic approach using Sodalis to deliver Nbs that
target the trypanosome-tsetse fly crosstalk could open
a new avenue to unravel the molecular determinants of
this specific parasite-vector association.Material and methods
Insects, bacterial strains and culture conditions
G. morsitans morsitans (Westwood) from the colony at
the Institute of Tropical Medicine Antwerp (ITM), origi-
nated from pupae collected in Kariba (Zimbabwe) and
Handeni (Tanzania), were used in all experiments. Flies,
maintained at 26°C and 65% relative humidity, were fed
3 days per week with defibrinated bovine blood using an
artificial membrane system. Sodalis glossinidius strains
used in this study were isolated from the haemolymph
of surface-sterilized tsetse flies from the colony main-
tained at ITM. Cultures were maintained in vitro at 27°C
in liquid Mitsuhashi-Maramorosch (MM) insect medium
(PromoCell) supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (FBS). Where appropriate, selection
antibiotics were added to the media at the following
concentrations: 100 μg/ml of ampicillin or 50 μg/ml of
kanamycin. Flies used in this study were maintained at
26°C and 65% relative humidity, and fed 3 days per week
with defibrinated bovine blood using an artificial mem-
brane system.Plasmid constructs
In this study the pFliCpelBNb46fliC plasmid was used in
which a 6 × His tagged Nb_An46 gene was fused to two
secretion signals (FliC and pelB) and cloned into the
multiple cloning site of the pCM66 expression vector.
The pFliCpelBNb46fliC plasmid was derived from pFliC-
pelBNb33fliC [12] by replacement of pelBNb_An33 be-
tween the XbaI and EcoRI sites by pelBNb_An46 amplified
as a XbaI-EcoRI fragment (465 bp) by PCR from the
pHen6C plasmid containing the pelBNb_An46 gene using
the following primer set: Nb46_FW, 5’-TCTAGAAT-
GAAATACCTATTGCCTACGG-3’ and Nb46_Rev, 5’-
GAATTCTTAGTGATGGTGATGGTGGTGGCGGCCG
CGTGAGGAGAC-3’ (XbaI-EcoRI restriction sites are
underlined).
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Sodalis transformation with the pFliCpelBNb46fliC plas-
mid was conducted using a heat-shock based method as
described in [14]. Following transformation, the cells
were allowed to recover overnight at 27°C in liquid MM
medium prior to plating.
Growth curve measurements
Logarithmically growing cultures were used to inoculate
25 ml of MM-medium to an optical density at 600 nm
(OD600) of 0.05. Sodalis cultures harboring the FliC-
pelBNb46fliC plasmid were allowed to grow without
shaking for the first 24 h, after which they were trans-
ferred to a shaking incubator. Samples were taken every
24 h for optical density measurements and Nb protein
quantification in culture supernatants and whole cell
extracts. The cell population doubling time was calculated
from the growth rate during exponential growing phase
using the following equation: doubling time (in hours) =
h*ln(2)/ln(c2/c1) where c1 is the initial concentration
and c2 is the concentration when cultures reached
maximum densities.
Plasmid copy number assay
The plasmid copy number per cell was calculated by
dividing the absolute copy number by the number of
Sodalis CFU present in the culture. The absolute num-
ber of plasmid and Sodalis CFU present in the Sod_Flic-
pelBNb46fliC culture grown in the presence of antibiotic
selection (kanamycin 50 μg/ml) was estimated by quan-
titative real-time PCR (qPCR) on DNA extracted from
culture samples taken during the lag and exponential
growth phases using the QIAGEN DNeasy extraction kit
(QIAGEN). PCR reactions were carried out on a Light-
Cycler™ (Roche Diagnostics, Mannheim, Germany). To
estimate the number of Sodalis CFU present in the
culture, a standard curve was generated using DNA
extracts from a serial dilution series (1:10) ranging
from 107 Sod_FlicpelBNb46fliC CFU/ml to 102 Sod_-
FlicpelBNb46fliC CFU/ml. For pFliCpelbNb46fliC plas-
mid number determination a dilution series (1:10)
ranging from 10-1010 plasmid copies μl−1 was prepared
to establish a linear standard curve for real-time PCR
assays. For Sodalis, primers that target a 120-bp region
of the single-copy S. glossinidius exochitinase gene were
used: Qchi_Fw, 5’- TGGGGACAGTACGATGGCAG
AGC −3 ; Qchi_Rev, 5’- TCATAGGCGGTCGGGGAT
AATTGCG -3’. For the plasmid number determination,
a 433-bp common region present on both pFliC-
pelBNb33fliC and pFliCpelBNb46fliC plasmids was
amplified using the following primer set: pCM66_Fw,
5’- CTTGGCCCTCACTGACAG-3’; pCM66_rev, 5’- G
CAGCCCTGGTTAAAAAC-3’. qPCR was performed in
a 20-μl reaction mixture volume containing 10 μl of2 × iQ™ SYBR green supermix, 0.3 μM of each primer,
template (DNA ) and RNase-free sterile water to a final
volume of 20 μl.
Measuring in vitro plasmid stability
The in vitro stability of the pFliCpelBNb46fliC plasmid
in Sodalis was measured by maintaining recombinant
bacteria in log phase growth for 27 generations in MM
without kanamycin selection. Samples were taken every
two to four generations and plated on MM blood agar
with and without kanamycin. The ratio of the number of
colony forming units (CFU) grown on the selective
blood agar plate to those grown on the non-selective
blood agar was used to determine the percentage of
plasmid-carrying cells. This ratio allows to monitor the
plasmid stability during subsequent generations in the
cultured recSodalis.
Western blot analysis
Cells were pelleted from bacterial cultures by centrifugation
(15 min, 10000 × g) and the supernatant was clarified from
residual bacterial cells by a second centrifugation step. Pro-
teins in the growth medium were precipitated with 10%
trichloroacetic acid (TCA) for 1 h on ice. For SDS-PAGE,
samples were heat denatured at 95°C in the presence of
SDS-PAGE loading buffer containing β-mercaptoethanol
and analyzed on a 12% (w/v) polyacrylamide gel (Biorad).
Proteins were transferred onto a Hybond C nitrocellulose
membrane (Whattman). After overnight blocking with 1%
(w/v) bovine serum albumin, the membrane was incubated
sequentially with a mouse anti-6 ×His-tag IgG1 antibody
(1:1000) (Serotec) and a rabbit anti-mouse-IgG antibody
(1:1000) (Serotec) conjugated to horseradish peroxidase. In
between these successive 2 h incubations, the membrane
was washed with PBS-0.1% Tween 20. Thirty minutes
after adding the substrate (TMB 1-Component Mem-
brane Peroxidase Substrate, KPL) the reaction was
stopped by washing the membrane with water.
RecSodalis introduction into tsetse flies
To evaluate the effect of reducing the WT Sodalis popu-
lation in tsetse on recSodalis growth inside its host,
newly emerged male G. morsitans morsitans flies were
divided into two experimental groups. The treated group
was given three blood meals supplemented with 20 μg/ml
streptozotocin while the non-treated group received
normal blood meals. Next, treated and non-treated flies
were briefly anaesthetized by cold shock and microin-
jected intrathoracically with a suspension of 5 × 104
Sod_pFliCpelBNb46fliC CFU, using a 5 μl Hamilton
75RN microsyringe with gauge 33 removable electrota-
pered needles. After injection, males were kept in separate
cages and received an antibiotics-free blood meal every
48 h throughout the course of the experiment.
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by injecting streptozotocin treated adult male flies with re-
spectively 5 × 104, 5 × 105, 107 and 5 × 107 CFU Sod_pFliC-
pelBNb46fliC followed by determination of the number of
recSodalis CFU in abdomen and thorax 7 and 14 days
post-injection.
To evaluate the in vivo persistence of Sod_pFliCpel-
BNb46fliC, streptozotocin treated adult male flies were
injected intrathoracically with 107 Sod_pFliCpelBNb46fliC
CFU. At different time points post-injection i.e. day 1 (ten-
eral), 7, 14, 21 and 28, the number of WT and recSodalis
CFU present in abdomen, thorax, haemolymph and midgut
was measured using qPCR. To evaluate the transmission of
recSodalis to the F1 progeny, streptozotocin-treated female
flies were injected intrathoracically with 5 × 104 Sod:pFliC-
pelBNb46fliC CFU. Females were allowed to mate with
WT males and their offspring (teneral stage) was evaluated
for the presence of recSodalis.
Measuring in vivo Sodalis and Wigglesworthia density
At various time points post-injection flies were sacrificed
for genomic DNA extraction using the QIAGEN DNeasy
extraction kit (QIAGEN). We used a quantitative PCR
(qPCR) method for the estimation of the number of WT
Sodalis and recSodalis cells in tsetse fly tissues (abdomen,
thorax, midgut and haemolymph). For this, triplicate cul-
tures of WT and recSodalis were serially diluted (10-fold)
in PBS to yield a Sodalis density ranging from 107 CFU/ml
to 102 CFU/ml. DNA was extracted from each Sodalis dilu-
tion followed by qPCR using primers that amplify a region
of the pCM66 plasmid backbone present in recSodalis:
(pCM66_Fw, 5’-CTTGGCCCTCACTGACAG-3’ and pC
M66_Rev, 5’- GCAGCCCTGGTTAAAAAC-3’) and
primers that target a 120-bp region of the single-copy
Sodalis glossinidius exochitinase (Qchi) gene to determine
the corresponding Ct values. Standard curves were gener-
ated by plotting these Ct values against the corresponding
log of Sodalis CFU/ml. This qPCR approach in combin-
ation with the Sodalis CFU standard curves allowed us to
estimate the CFU (DNA equivalent) values present in the
tsetse fly tissues of the different experimental fly series.
An internal control was included to evaluate the DNA
extraction efficiency in all the tissue samples. For this,
samples were spiked with 0.4 ng of plasmid DNA
(pBAD24_GFP) prior to extraction. qPCR with gfp-spe-
cific primers (pBAD24_GFP: GFP_Fw, 5’-TGGCCAAC
ACTTGTCACTAC-3’ and GFP_Rev, 5’-AGAAGGACC
ATGTGGTC-3’) revealed a Ct value of approximately
24.5 in all the DNA extracts corresponding to the Ct
value of the plasmid dilution used to spike to internal
control alone demonstrating a uniform highly efficient
extraction of the DNA in all the samples.
Wigglesworthia quantification was done by amplifying
the thiamine locus with the following primer set: QthiC_F,5’-AAGTTATGATAGAAGGACCAGGAC-3’ and QthiC_
R, 5’-CCCGGAGCAATATCAGTAGTTAG-3’. All Ct
values were normalized to the G. morsitans morsitans refer-
ence gene β-actin for each sample using the following pri-
mer set: β-actin_F, 5’-GGCTTCTGGTCGTACTACT-3’
and β-actin_R, 5’-CCGGACATCACAATGTTGG-3’. For
each sample the obtained Ct value of the thiamine gene
was normalized to the Ct value of the reference gene (β-
actin) by subtracting the β-actin Ct value from the thiamine
Ct value to yield a ΔCt value for each sample. ΔCt values
were log-transformed and compared using the Mann–
Whitney U test to establish differences among treated and
control groups. A value of p <0.05 was considered signifi-
cant in all analyses.
qPCR was performed in a 20-μl reaction mixture vol-
ume containing 10 μl of 2 × iQ™ SYBR green supermix,
0.3 μM of each primer, template (genomic DNA, stand-
ard) and RNase-free sterile water to a final volume of
20 μl. The amount of fluorescence generated was mea-
sured during each amplification cycle using the following
program: (i) initial denaturing at 95°C for 3 min; (ii)
40 cycles, with 1 cycle consisting of denaturation at 95°C
for 10 s, annealing at 60°C for 10 s, and extension at 72°C
for 30 s. All assays were carried out on a LightCycler™
(Roche Diagnostics, Mannheim, Germany) in 96-well for-
mat plates in duplicate and were averaged for each sample.
For each PCR run, a negative (no-template) control was
used to test for false-positive results or contamination.
Analysis of in vitro and in vivo Nanobody concentrations
using ELISA
i. In vitro. The amount of active Nb_An46 present in
cytoplasmic extracts and growth medium was
quantified using an optimized nanobody-detection
ELISA [19]. For this purpose, Maxisorb 96-well
plates (Nunc) were coated overnight (4°C) with
200 ng purified soluble AnTat 1.1 VSG per well in
0.1 M NaHCO3, pH 8.2. Residual protein binding
sites were blocked for two hours at room temperature
with 0.5% bovine serum albumin (BSA) in PBS.
Standards and samples were added for 1 h at room
temperature. Detection of antigen-bound nanobodies
was performed with a mouse anti-6 × His IgG
antibody (Serotec) directly conjugated to horseradish
peroxidase. Thirty minutes after adding peroxidase
substrate, the reaction was stopped with 0.33 M
H2SO4 and the optical density was measured at
450 nm (690 nm was used as reference filter). Protein
concentrations were calculated from a standard curve
fitted to a four parameter logistic equation using the
Ascent software (Labsystems). Samples from the
in vitro Sodalis culture were taken at the same time
points indicated for the growth curve measurements.
For each sample, 1 ml of culture media was centrifuged
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whole cell fractions. The whole cell extracts were
prepared by resuspending the cell pellets in 0.2 ml PBS
supplemented with complete protease inhibitor (Roche)
followed by sonication at an amplitude of 10 microns
for 5 seconds (3 cycles on ice). For quantification of
Nb_An46 present in cytoplasmic extracts and growth
medium, a standard serial dilution series (1:2) starting
from 2500 to 5 ng/ml of purified Nb_An46 was
prepared in PBS and MM-medium respectively. MM
medium and PBS alone were included as blanks.
ii. In vivo. Quantification of active Nb_An46 present in
different tsetse fly tissues samples (abdomen, thorax,
midgut and haemolymph) was performed at different
time points post-injection. The preparation of
the whole tissue extracts by sonication and the
Nb-quantification by ELISA were performed as
described above. To mimic the sample complexity
of the abdomen, thorax, midgut and haemolymph
extracts, nanobody standards were prepared in the
corresponding tissue extracts from non-injected
wildtype flies. The respective tissues from flies
harboring WT Sodalis were included as blanks.
Additional file
Additional file 1: Figure S1. The presence of Wigglesworthia in abdomen
tissues from streptozotocin treated and non-treated male flies. Figure S2. The
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